1 Van Inwegen, R.G., Khandwala, A., Gordon, R., et al. REV 5901: An orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile. J Pharmacol Exp Ther 241 117-124 (1987).

2 Musser, J.H., Charkraborty, U.R., Sciortino, S., et al. Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists. J Med Chem 30 96-104 (1987).

McMillan, R.M., and Walker, E.R.H. Designing therapeutically effective 5-lipoxygenase inhibitors. Trends Pharmacol Sci 13 323-330 (1992).

Van Inwegen, R.G., Khandwala, A., Gordon, R., et al. REV 5901: An orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile. J Pharmacol Exp Ther 241 117-124 (1987).

Musser, J.H., Charkraborty, U.R., Sciortino, S., et al. Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists. J Med Chem 30 96-104 (1987).

Hogaboam, C.M., Donigi-Gale, D., Shoupe, T.S., et al. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. Br J Pharmacol 105 87-92 (1992).

REV 5901 is available in the following screening library:

• Bio-active Lipid I Screening Library (96-Well)